Analysis of transient and reversible effects of poly-L-arginine on the in vivo nasal absorption of FITC-dextran in rats

被引:43
作者
Ohtake, K
Natsume, H
Ueda, H
Morimoto, Y
机构
[1] Josai Univ, Fac Pharmaceut Sci, Sakado, Saitama 3500295, Japan
[2] Res Inst TTS Technol, Sakado, Saitama 3500295, Japan
关键词
nasal drug delivery system; absorption enhancer; reversible enhancement; paracellular permeability; poly-L-arginine;
D O I
10.1016/S0168-3659(02)00128-1
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
We have investigated whether poly-L-arginine, with a mean molecular weights of 8.9 and 45.5 kDa (poly-L-Arg (10) and poly-L-Arg (50)), can induce transient and reversible effects involving enhancement of the nasal absorption of fluorescein isothiocyanate-labeled dextran (MW 4.4 kDa, FD-4) and determined the main pathway for the increased transport of FD-4 in,A rats in vivo. Pre-administration and repeated administration studies were conducted involving the selection of different time intervals between intranasal administration of poly-L-Arg and administration of FD-4, with and without poly-L-Arg, to characterize these transient and reversible effects. The degradation of poly-L-Args in a diluted nasal drip was determined from the fluorescence of degraded poly-L-Arg-fluorescamine products. In the pre-administration study, poly-L-Arg exhibited a transient effect on the increased nasal FD-4 absorption depending on its molecular weight, associated with the degradation rate of poly-L-Arg in mucus. In the repeated administration study, additional poly-L-Arg produced similarly enhanced FD-4 absorption. Confocal laser scanning microscopy showed that fluorescence of FD-4 after co-administration of poly-L-Arg (50) was confined mainly to the paracellular spaces. In conclusion, poly-L-Arg exhibited molecular weight-dependent transient and reversible effects on the enhancement of nasal FD-4 absorption paracellularly in rats in vivo. The enzymatic degradation of poly-L-Arg is one of the key determinants of the transient effect on in vivo enhanced absorption of FD-4. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:263 / 275
页数:13
相关论文
共 27 条
  • [1] EFFECT OF CHITOSAN ON THE PERMEABILITY OF MONOLAYERS OF INTESTINAL EPITHELIAL-CELLS (CACO-2)
    ARTURSSON, P
    LINDMARK, T
    DAVIS, SS
    ILLUM, L
    [J]. PHARMACEUTICAL RESEARCH, 1994, 11 (09) : 1358 - 1361
  • [2] ASPEN TJ, 1996, EUR J PHARM SCI, V4, P23
  • [3] FLUOROMETRIC ASSAY OF PROTEINS IN NANOGRAM RANGE
    BOHLEN, P
    STEIN, S
    DAIRMAN, W
    UDENFRIEND, S
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1973, 155 (01) : 213 - 220
  • [4] Chien Y. W., 1989, NASAL SYSTEMIC DRUG
  • [5] El-Hameed M. D. Abd, 1997, EUR J PHARM BIOPHARM, V44, P53
  • [6] FISHER AN, 1990, PROG DRUG METAB, V12, P87
  • [7] A PROTEASE INHIBITOR FROM HUMAN ALLERGIC NASAL SECRETIONS
    FUKUDA, K
    ITOH, K
    OOYAMA, T
    [J]. ACTA OTO-LARYNGOLOGICA, 1987, 104 (5-6) : 539 - 544
  • [8] HAMMES M, 1994, J LAB CLIN MED, V123, P437
  • [9] HIRAI S, 1981, INT J PHARM, V9, P165
  • [10] HOSOYA K, 1994, BIOL PHARM BULL, V17, P316